BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38533011)

  • 1. Computational investigation of turmeric phytochemicals targeting PTR1 enzyme of
    Ullah W; Wu WF; Malak N; Nasreen N; Swelum AA; Marcelino LA; Niaz S; Khan A; Ben Said M; Chen CC
    Heliyon; 2024 Mar; 10(6):e27907. PubMed ID: 38533011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational studies on potential small molecule inhibitors of
    Boakye A; Gasu EN; Mensah JO; Borquaye LS
    J Biomol Struct Dyn; 2023; 41(21):12128-12141. PubMed ID: 36632757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Silico Identification and In Vitro Evaluation of Natural Inhibitors of Leishmania major Pteridine Reductase I.
    Herrmann FC; Sivakumar N; Jose J; Costi MP; Pozzi C; Schmidt TJ
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29211037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico and In Vitro Search for Dual Inhibitors of the
    Possart K; Herrmann FC; Jose J; Schmidt TJ
    Molecules; 2023 Nov; 28(22):. PubMed ID: 38005256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
    Hardy LW; Matthews W; Nare B; Beverley SM
    Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major.
    Nare B; Hardy LW; Beverley SM
    J Biol Chem; 1997 May; 272(21):13883-91. PubMed ID: 9153248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico molecular docking studies of new potential 4-phthalazinyl-hydrazones on selected Trypanosoma cruzi and Leishmania enzyme targets.
    Romero AH; López SE
    J Mol Graph Model; 2017 Sep; 76():313-329. PubMed ID: 28763686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major.
    Bello AR; Nare B; Freedman D; Hardy L; Beverley SM
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11442-6. PubMed ID: 7972081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiadiazine-thiones as inhibitors of leishmania pteridine reductase (PTR1) target: investigations and in silico approach.
    Shtaiwi A
    J Biomol Struct Dyn; 2023 Aug; ():1-10. PubMed ID: 37578348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and Genetic Tests for Inhibitors of Leishmania Pteridine Pathways.
    Hardy LW; Matthews W; Nare B; Beverley SM
    Exp Parasitol; 1997 Nov; 87(3):158-70. PubMed ID: 9398595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
    Nare B; Luba J; Hardy LW; Beverley S
    Parasitology; 1997; 114 Suppl():S101-10. PubMed ID: 9309772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An
    Baikerikar S
    Pharmacognosy Res; 2017 Dec; 9(Suppl 1):S15-S22. PubMed ID: 29333037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning, expression and enzymatic assay of pteridine reductase 1 from Iranian lizard Leishmania.
    Kazemi B; Tohidi F; Bandehpour M; Yarian F
    Iran Biomed J; 2010 Jul; 14(3):97-102. PubMed ID: 21079660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
    Tulloch LB; Martini VP; Iulek J; Huggan JK; Lee JH; Gibson CL; Smith TK; Suckling CJ; Hunter WN
    J Med Chem; 2010 Jan; 53(1):221-9. PubMed ID: 19916554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy.
    Cunningham ML; Beverley SM
    Mol Biochem Parasitol; 2001 Apr; 113(2):199-213. PubMed ID: 11295174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the
    Shamshad H; Hafiz A; Althagafi II; Saeed M; Mirza AZ
    Curr Comput Aided Drug Des; 2020; 16(5):583-598. PubMed ID: 31453790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization and functional analysis of pteridine reductase in wild-type and antimony-resistant Leishmania lines.
    de Souza Moreira D; Ferreira RF; Murta SM
    Exp Parasitol; 2016 Jan; 160():60-6. PubMed ID: 26689884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of pteridine reductase 1 (PTR1) enzyme during growth phase in the protozoan parasite Leishmania donovani.
    Kumar P; Sundar S; Singh N
    Exp Parasitol; 2007 Jun; 116(2):182-9. PubMed ID: 17275814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the inhibitory activity of Withaferin-A against Pteridine reductase-1 of L. donovani.
    Chandrasekaran S; Veronica J; Gundampati RK; Sundar S; Maurya R
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1029-37. PubMed ID: 26406482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum.
    Bhattacharya A; Leprohon P; Ouellette M
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009377. PubMed ID: 33905412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.